Chronic treatment with haloperidol diminishes the phencyclidine-induced sensorimotor gating deficit in rats

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 357, Issue 4, 1998, Pages 466-471

  Pietraszek, Małgorzata ^a   Ossowska, Krystyna ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Antipsychotic action; Chronic haloperidol; Phencyclidine; Prepulse inhibition

Indexed keywords

HALOPERIDOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHENCYCLIDINE;

ANIMAL EXPERIMENT; ARTICLE; AUDITORY STIMULATION; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; LONG TERM CARE; MALE; NONHUMAN; PERCEPTIVE THRESHOLD; PREPULSE INHIBITION; RAT; SCHIZOPHRENIA; SENSORIMOTOR FUNCTION; STARTLE REFLEX;

ANIMALS; ANTIPSYCHOTIC AGENTS; DRUG ANTAGONISM; EXCITATORY AMINO ACID ANTAGONISTS; HALOPERIDOL; MALE; PHENCYCLIDINE; RATS; RATS, WISTAR; STARTLE REACTION; TIME FACTORS;

EID: 0031956967     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00005194     Document Type: Article

References (32)

1. Bakshi VP, SwErdlow NR, Geyer MA (1994) Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. J Pharmacol Exp Ther 271:787-794
2. Bakshi VP, Geyer MA (1995) Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antypsychotic olanzapine. Psychopharmacology 122:198-201
3. Banerjee SP, Zuck LG, Yahlonsky-Alter E, Lidsky TI (1995) Glutamate agonist activity: implications for antipsychotic drug action and schizophrenia. NeuroReport 6:2500-2504
4. Bunney BG, Bunney WE, Carlsson A (1995) Schizophrenia and glutamate. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: the fourth generation of progress. Raven Press, Ltd, New York, pp 1205-1214
5. Fletcher EJ, MacDonald JF (1993) Haloperidol interacts with the strychnine-insensitive glycine site as the NMDA receptor in cultured mouse hippocampal neurones. Eur J Pharmacol 235:291-295
6. Furuya Y, Ogura H (1997) Competitive NMDA and strychnine-insensitive glycine-site antagonists disrupt prepulse inhibition. Pharmacol Biochem Behav 57:909-913
7. Geyer MA, Swerdlow NR, Manshach RS, Braff DL (1990) Startle response models of sensorimotor gating and habituation deficits in schizophrenia. Brain Res Bull 25:485-498
8. Huffman DC, Donovan H, Cassella JV (1993) The effects of haloperidol and clozapine on the disruption of sensorimotor gating induced by the noncompetitive glutamate antagonist MK-801. Psychopharmacology 111:339-344
9. Holley FO, Magliozzi JR, Stanski DR, Lombrozo L, Hollister LE (1983) Haloperidol kinetics after oral and intravenous doses. Clin Pharmacol Ther 33:477-484
10. Jackson DM, Johansson C, Lindgren L-M, Bengtsson A (1994) Dopamine receptor antagonists block amphetamine and phencyclidine-induced motor stimulation in rats. Pharmacol Biochem Behav 48:465-471
11. Johansson C, Jackson DM, Svensson L (1994) The atypical antipsychotic, remoxipride, blocks phencyclidine-induced disruption of prepulse inhibition in the rat. Psychopharmacology 16:437-442
12. Keith VA, Mansbach RS, Geyer MA (1991) Failure of haloperidol to block the effect of phencyclidine and dizoilpine on prepulse inhibition of startle. Biol Psychiatry 30:557-566
13. Keck PE Jr, Cowen BM, Baldessarini RJ, McElroy SL (1989) Time course of antipsychotic effcts of neuroleptic drugs. Am J Psychiatry 146:1289-1292
14. Kim JS, Kornhuber HH, Schmid-Burgk W, Holzmüller B (1980) Low cerebrospinal fluid glutamate in schiyophrenic patients and a new hypothesis on schizophrenia. Neurosci Lett 20:379-382
15. Lidsky TI, Yahlonsky-Alter E, Zuck LG, Banerjee SP (1997) Antypsychotic drug effects on glutamalergic activity. Brain Res 764:46-52
16. Luisada PV, Brown BI (1976) Clinical management of the phencyclidine psychosis. Clin Toxicol 9:539-545
17. Manshach RS, Geyer MA (1989) Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat. Neuropsychopharmacology 2:299-308
18. Mansbach RS, Geyer MA, Braff DL (1988) Dopaminergic stimulation disrupts sensorimotor gating. Psychopharmacology 94:507-514
19. McCoy L, Richfield EK (1996) Chronic antipsychotic treatment alters glycine-stimulated NMDA receptor binding in rat brain. Neurosci Lett 213:137-141
20. Meltzer HY, Stahl SM (1976) The dopamine hypothesis of schizophrenia: a review. Schizophrenia Bull 2:19-76
21. Ögren SO, Goldstein M (1994) Phencyclidine- and dizocilpine-induced hyperlocomotion are differentially mediated. Neuropsychopharmacology 11:167-177
22. Rigdon GC, Viik K (1991) Prepulse inhibition as a screening test for potential antipsychotics. Drug Dev Res 23:91-99
23. Sherman AD, Davidson AT, Barnuh S, Hegwood TS, Waziri R (1991) Evidence of glutamatergic deficiency in schizophrenia. Neurosci Lett 121:77-80
24. Snell LD, Mueller ZL, Gannon RL, Silverman PB, Johnson KM (1984) A comparison between classes of drugs having phencyclidine-like behavioral properties on dopamine efflux in vitro and dopamine metabolism in vivo. J Pharmacol Exp Ther 231:261-269
25. Snell LD, Yi S-J, Johnson KM (1988) Comparison of the effect of MK-801 and phencyclidine on catecholamine uptake and NMDA-induced norepinephrine relase. Eur J Pharmacol 145:233-226
26. Swerdlow NR, Keith VA, Braff DL, Geyer MA (1991) Effects of spiperone, raclopride, SCH 23390 and clozapine on apomorphine inhibition of sensorimotor gating of the startle response in the rat. J Pharmacol Exp Ther 256:530-536
27. Swerdlow NR, Caine CB, Geyer MA (1992) Regionally selective effects of intracerebral dopamine infusion on sensorimotor gating of the startle reflex in rats. Psychopharmacology 108:189-195
28. Swerdlow NR, Bakshi V, Geyer MA (1996) Seroquel restores sensorimotor gating in phencyclidine-treated rats. J Pharmacol Exp Ther 279:1290-1299
29. Toru M, Kurumaji A, Kumashiro S, Suga I, Tamashima M, Nishikawa T (1992) Excitatory amino acidergic neurones in chronic schizophrenic brain. Mol Neuropharmacol 2:241-243
30. Tsai G, Passani LA, Slusher BS, Carter R, Baer L, Kleinman JE, Coyle JT (1995) Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Arch Gen Psychiatry 52:829-836
31. Ułas J, Nguyen L, Cotman CW (1993) Chronic haloperidol treatments enhances binding to NMDA receptors in rat cortex. NeuroReport 4:1049-1051
32. Wȩdzony K, Gołcmbiowska K, Zazula M (1994) Differential effects of CGP 37849 and MK-801, competitive and noncompetitive NMDA antagonists, with respect to the modulation of sensorimotor gating and dopamine outflow in the prefrontal cortex of rats. Naunyn-Schmiedeberg's Arch Pharmacol 350:555-562